TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.90
0.00 (0.00%)
Dec 20, 2024, 1:30 PM CST
-29.45%
Market Cap 7.82B
Revenue (ttm) 148.75M
Net Income (ttm) 171.74M
Shares Out 717.84M
EPS (ttm) 0.24
PE Ratio 45.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 782,453
Open 10.95
Previous Close 10.90
Day's Range 10.90 - 11.15
52-Week Range 10.80 - 17.25
Beta 0.76
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About TaiGen Biopharmaceuticals Holdings

TaiGen Biopharmaceuticals Holdings Limited, a pharmaceutical company, develops novel therapeutics for transformative diseases worldwide. The company develops Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic for the treatment of bacterial infections. It is also developing Taigexyn for treating community-acquired pneumonia and diabetic foot infection, as well as other bacterial infections; Burixafor, a stem cell mobilizer for stem cell transplantation and chemosenzitization; TG-1000, an influenza antiviral drug for treating influenz... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 4157
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.